Federated Hermes’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.67M | Buy |
298,201
+113,297
| +61% | +$1.02M | 0.01% | 868 |
|
2025
Q1 | $1.39M | Buy |
184,904
+16,947
| +10% | +$127K | ﹤0.01% | 1026 |
|
2024
Q4 | $1.26M | Buy |
167,957
+56,930
| +51% | +$428K | ﹤0.01% | 1044 |
|
2024
Q3 | $844K | Buy |
+111,027
| New | +$844K | ﹤0.01% | 1180 |
|
2022
Q2 | – | Sell |
-348
| Closed | -$6K | – | 2149 |
|
2022
Q1 | $6K | Sell |
348
-47,893
| -99% | -$826K | ﹤0.01% | 1933 |
|
2021
Q4 | $668K | Sell |
48,241
-819,896
| -94% | -$11.4M | ﹤0.01% | 1401 |
|
2021
Q3 | $12.5M | Buy |
868,137
+121,166
| +16% | +$1.74M | 0.02% | 592 |
|
2021
Q2 | $11.8M | Buy |
746,971
+722,057
| +2,898% | +$11.4M | 0.02% | 602 |
|
2021
Q1 | $253K | Buy |
24,914
+24,750
| +15,091% | +$251K | ﹤0.01% | 1669 |
|
2020
Q4 | $1K | Buy |
+164
| New | +$1K | ﹤0.01% | 2156 |
|
2019
Q4 | – | Sell |
-331,172
| Closed | -$949K | – | 2211 |
|
2019
Q3 | $949K | Sell |
331,172
-277,144
| -46% | -$794K | ﹤0.01% | 1287 |
|
2019
Q2 | $2.31M | Sell |
608,316
-171,090
| -22% | -$649K | 0.01% | 1017 |
|
2019
Q1 | $6.34M | Buy |
779,406
+343,269
| +79% | +$2.79M | 0.02% | 711 |
|
2018
Q4 | $3.52M | Buy |
436,137
+434,756
| +31,481% | +$3.51M | 0.01% | 840 |
|
2018
Q3 | $11K | Buy |
+1,381
| New | +$11K | ﹤0.01% | 1937 |
|
2017
Q3 | – | Sell |
-69,320
| Closed | -$385K | – | 2136 |
|
2017
Q2 | $385K | Sell |
69,320
-182,740
| -72% | -$1.01M | ﹤0.01% | 1432 |
|
2017
Q1 | $2.12M | Buy |
252,060
+168,225
| +201% | +$1.41M | 0.01% | 884 |
|
2016
Q4 | $531K | Buy |
83,835
+2,983
| +4% | +$18.9K | ﹤0.01% | 1282 |
|
2016
Q3 | $357K | Sell |
80,852
-23,722
| -23% | -$105K | ﹤0.01% | 1373 |
|
2016
Q2 | $297K | Buy |
+104,574
| New | +$297K | ﹤0.01% | 1405 |
|
2016
Q1 | – | Sell |
-1,000
| Closed | -$10K | – | 2100 |
|
2015
Q4 | $10K | Buy |
+1,000
| New | +$10K | ﹤0.01% | 1790 |
|